ESC 365 - Lower rate of ischemic events with alirocumab in patients with atherosclerotic cardiovascular disease but without prior acute ischemic events

ESC2025 Premium Access

Lower rate of ischemic events with alirocumab in patients with atherosclerotic cardiovascular disease but without prior acute ischemic events

Session: Improving pharmacotherapy in primary prevention

Topic: Lipid-Lowering Agents

Speaker: Professor D. Bhatt (New York, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York (United States of America)

52 presentations

12 followers

5 more presentations in this session

Lipid management in high cardiovascular risk patients without prior myocardial infarction or stroke - preliminary data from the VESALIUS-REAL global burden study

Speaker: Doctor Q. Chan (Greater London, GB)

Cardiovascular risks of ibuprofen versus naproxen: a target trial emulation

Speaker: Doctor A. Bech-Drewes (Aarhus, DK)

Aspirin for the primary prevention of major adverse cardiovascular events in patients with elevated lipoprotein(a): a meta-analysis

Speaker: Doctor P. Lee (Bronx, US)

Efficacy of inclisiran in patients affected by familial hypercholesterolemia: data from CHOLINET Registry

Speaker: Doctor C. Cotticelli (Naples, IT)

Cardiorenal protective therapy for CKD: Real world data from the Hellenic Cardiorenal Morbidity Snapshots (HECMOS)

Speaker: Doctor I. Leontsinis (Athens, GR)

Access the full session

Improving pharmacotherapy in primary prevention

Speakers: Professor D. Bhatt, Doctor Q. Chan, Doctor A. Bech-Drewes, Doctor P. Lee, Doctor C. Cotticelli...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources